P
ProMIS Neurosciences, Inc. (PMN)
NCM – Real Time Price. Currency in USD
10.49
-0.19 (-1.78%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
10.49
-0.19 (-1.78%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.88 | 6.05 | 5.0 | |
| Quick ratio | 0.88 | 5.63 | 5.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 4.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -11K | -21K | N/A | N/A | N/A |
| Operating Income | -23M | -14M | -17M | -40M | -40M |
| Net Income | -18M | -13M | 3M | -40M | -40M |
| EBITDA | -23M | -14M | -17M | -40M | -40M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 79.81 | 5.5 |
| Next quarter | N/A | 84.69 | 5.5 |
| Current year | N/A | 80.63 | 5.5 |
| Next year | N/A | 8.22 | 3.5 |
| Weighted average score | 5.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 7.82 | 31.5 | 11.17 | 8.3 |
| Y/Y | 999 | -4381 | -236.99 | -9.93 | 3.3 |
| 3y average | 999 | -460.47 | -252.09 | -39.24 | 3.3 |
| 5y average | 755.89 | -319.24 | -182.58 | -76.38 | 3.3 |
| Weighted average score | 4.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $6.1M barely cover the upcoming debt maturities $0.0
Total current liabilities $10.4M surpass Total current assets $9.2M, signaling liquidity issues
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$9.1M limits the company's ability to reinvest or pay down debt